ArticleMicrobial cell factories2025
Engineering Pichia pastoris for the efficient production of the high-value steroid intermediate 15α-OH-D-ethylgonendione.
Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Early bioprocess development using Komagataella phaffii: application scenarios for the microTOM mini bioreactor system.Journal of biological engineering · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
15α-OH-D-ethylgonendione (15α-OH-DE) is a key intermediate for the synthesis of steroid drug gestodene, a major component of a new generation of powerful contraceptives. Synthetic access to 15α-OH-DE by chemical means is limited by low titers and generation of toxic byproducts. To develop a sustainable process for 15α-OH-DE production, a whole-cell catalyst was constructed by engineering Pichia pastoris co-overexpressing the PRH gene from filamentous fungus Penicillium raistrickii, which encodes a steroid 15α-hydroxylase capable of selectively 15α-hydroxylating DE, and the glucose-6-phosphate dehydrogenase gene ZWF1 from the baker's yeast for enhanced NADPH production. Shake-flask cultivation was performed to optimize fermentation parameters and assess the potential of the engineered P. pastoris strains for 15α-OH-DE production. Subsequently, production was scaled up using a fed-batch strategy in a 5-L stirred-tank bioreactor, with pure methanol serving as both the carbon source and inducer. This process achieved a product titer of 5.79 g L⁻¹ with DE feeding of 10 g L
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.